Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Home Access HIV testing system cleared for marketing in U.S.

Aug. 16, 1996

BCT launched in U.S.

Aug. 16, 1996

Bard to comarket ProstaScint with Cytogen

Aug. 16, 1996

White Iris leukocyte differential analyzer cleared for U.S. market

Aug. 9, 1996

OncorMed to offer genetic testing for BRC2 mutations

Aug. 9, 1996

BRACAone undergoes beta-site testing in U.S.

Aug. 9, 1996

Cyogen's ProstaScint on its way to FDA approval

July 26, 1996

Oncor obtains license to p43 blood test for early-stage breast cancer

July 26, 1996

ICD grants exclusive rights of DR-70 to Y.H. BioTek

July 26, 1996

Quidel's QuickVue Chlamydia Test approved in Germany

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 3, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 3, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
First atlas of the endometrium with polycystic ovary syndrome
BioWorld Science
Although the causes of polycystic ovary syndrome (PCOS) are unclear, researchers know this condition leads to endometrial dysfunction in women who have hormonal...
Impact of Trump tariffs on med tech proving difficult to anticipate
BioWorld MedTech
The Trump administration’s declaration of a new round of tariffs did not sit well with trade associations, but the impact of those tariffs may vary somewhat by...